Key data from the 11th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV.
The effectiveness of current antiretroviral therapies has led to more patients receiving long-term therapy, and increasing numbers of older patients. The complex interactions between HIV infection, ageing, comorbid conditions and drug-related toxicities, and their combined effects on patient health and quality of life, were the subject of the 11th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV. Key topics included the metabolic effects of antiretroviral agents, cardiovascular disease, bone metabolism and age-related changes in disease and response to drug therapy. Data presented at the meeting reflect the growing recognition of common pathways that contribute to progression of mutiple types of disease and adverse drug reactions.
Boehme
Richard E
RE
International Medical Press, Hamilton, NJ, USA.
Cameron
Stephen
S
D017088:AIDS-Related Opportunistic Infections / Q000139:chemically induced; D000367:Age Factors; D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000378:metabolism; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D001842:Bone and Bones / Q000378:metabolism; D002318:Cardiovascular Diseases / Q000139:chemically induced; D064420:Drug-Related Side Effects and Adverse Reactions / Q000139:chemically induced*; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy / Q000821:virology; D015497:HIV-1 / Q000187:drug effects; D039682:HIV-Associated Lipodystrophy Syndrome / Q000139:chemically induced; D006801:Humans; D016896:Treatment Outcome
D019380:Anti-HIV Agents